These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 16923558)
1. Late effects of treatment on growth in childhood non-Hodgkin's lymphoma. Oğuz A; Pinarli FG; Karadeniz C; Bideci A; Ozkan S Leuk Lymphoma; 2006 Jul; 47(7):1283-9. PubMed ID: 16923558 [TBL] [Abstract][Full Text] [Related]
2. Growth and growth hormone secretion after treatment for childhood non-Hodgkin's lymphoma. Samuelsson BO; Márky I; Rosberg S; Albertsson-Wikland K Med Pediatr Oncol; 1997 Jan; 28(1):27-34. PubMed ID: 8950333 [TBL] [Abstract][Full Text] [Related]
3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal growth in children with non-Hodgkin's lymphoma and children with acute lymphoblastic leukemia: comparison between unirradiated and irradiated patients. Márky I; Samuelsson BO; Mellander L; Karlberg J Med Pediatr Oncol; 1991; 19(2):96-9. PubMed ID: 2011102 [TBL] [Abstract][Full Text] [Related]
5. [Hungarian experience with non-Hodgkin's lymphoma in childhood]. Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787 [TBL] [Abstract][Full Text] [Related]
6. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Holm K; Nysom K; Rasmussen MH; Hertz H; Jacobsen N; Skakkebaek NE; Krabbe S; Müller J Bone Marrow Transplant; 1996 Jul; 18(1):163-70. PubMed ID: 8832010 [TBL] [Abstract][Full Text] [Related]
7. An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Ahmed SF; Wallace WH; Kelnar CJ Horm Res; 1997; 48(4):178-83. PubMed ID: 9378464 [TBL] [Abstract][Full Text] [Related]
8. The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children. Turan S; Bereket A; Furman A; Omar A; Berber M; Ozen A; Akbenlioglu C; Haklar G Eur J Clin Nutr; 2007 Jun; 61(6):752-8. PubMed ID: 17164829 [TBL] [Abstract][Full Text] [Related]
9. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H; Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465 [TBL] [Abstract][Full Text] [Related]
10. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836 [TBL] [Abstract][Full Text] [Related]
11. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency. Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia. Vilela MI; Viana MB Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045 [TBL] [Abstract][Full Text] [Related]
14. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children. Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968 [TBL] [Abstract][Full Text] [Related]
15. [Effect of various therapeutic protocols on growth and final height of children with acute lymphoblastic leukemia or non-Hodgkin's lymphoma]. Timme J; Mittler U; Mohnike K; Dörffel W Klin Padiatr; 1995; 207(5):267-70. PubMed ID: 7500601 [TBL] [Abstract][Full Text] [Related]
16. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma]. Kamieńska E Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116 [TBL] [Abstract][Full Text] [Related]
17. Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphoma. van Waas M; Neggers SJ; Te Winkel ML; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM Ann Oncol; 2012 Jun; 23(6):1626-32. PubMed ID: 22048153 [TBL] [Abstract][Full Text] [Related]
18. Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma. Thun-Hohenstein L; Frisch H; Schuster E Horm Res; 1992; 37(3):91-5. PubMed ID: 1478629 [TBL] [Abstract][Full Text] [Related]
19. Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia. Rastogi MV; Stork L; Druker B; Blasdel C; Nguyen T; Boston BA Pediatr Blood Cancer; 2012 Nov; 59(5):840-5. PubMed ID: 22378641 [TBL] [Abstract][Full Text] [Related]
20. Changes in growth pattern, body composition and biochemical markers of growth after adenotonsillectomy in prepubertal children. Ersoy B; Yücetürk AV; Taneli F; Urk V; Uyanik BS Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1175-81. PubMed ID: 15885810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]